E-cadherin inactivation underpins the progression of invasive lobular breast carcinoma (ILC). In ILC, p120-catenin (p120) translocates to the cytosol where it controls anchorage independence through the Rho-Rock signaling pathway, a key mechanism driving tumor growth and metastasis. We now demonstrate that anchorage-independent ILC cells show an increase in nuclear p120, which results in relief of transcriptional repression by Kaiso. To identify the Kaiso target genes that control anchorage independence we performed genome-wide mRNA profiling on anoikis-resistant mouse ILC cells, and identified 29 candidate target genes, including the established Kaiso target Wnt11. Our data indicate that anchorage-independent upregulation of Wnt11 in ILC c...
Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term la...
Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term la...
Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term la...
E-cadherin inactivation underpins the progression of invasive lobular breast carcinoma (ILC). In ILC...
E-cadherin inactivation underpins the progression of invasive lobular breast carcinoma (ILC). In ILC...
Chapter One provides a synopsis on the different functions of p120 in adhesion and beyond including ...
Loss of E-cadherin expression is causal to the development of invasive lobular breast carcinoma (ILC...
Loss of E-cadherin expression is causal to the development of invasive lobular breast carcinoma (ILC...
Invasive lobular breast cancer (ILC) is a subtype of breast cancer accounting for 10-15% of all inva...
Chapter 1 gives a general overview on epithelial homeostasis and the diverse functions p120 fulfills...
Invasive lobular breast cancer (ILC) is a subtype of breast cancer accounting for 10-15% of all inva...
Although mutational inactivation of E-cadherin (CDH1) is the main driver of invasive lobular breast ...
Spatiotemporal activation of RhoA and actomyosin contraction underpins cellular adhesion and divisio...
Although mutational inactivation of E-cadherin (CDH1) is the main driver of invasive lobular breast ...
Spatiotemporal activation of RhoA and actomyosin contraction underpins cellular adhesion and divisio...
Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term la...
Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term la...
Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term la...
E-cadherin inactivation underpins the progression of invasive lobular breast carcinoma (ILC). In ILC...
E-cadherin inactivation underpins the progression of invasive lobular breast carcinoma (ILC). In ILC...
Chapter One provides a synopsis on the different functions of p120 in adhesion and beyond including ...
Loss of E-cadherin expression is causal to the development of invasive lobular breast carcinoma (ILC...
Loss of E-cadherin expression is causal to the development of invasive lobular breast carcinoma (ILC...
Invasive lobular breast cancer (ILC) is a subtype of breast cancer accounting for 10-15% of all inva...
Chapter 1 gives a general overview on epithelial homeostasis and the diverse functions p120 fulfills...
Invasive lobular breast cancer (ILC) is a subtype of breast cancer accounting for 10-15% of all inva...
Although mutational inactivation of E-cadherin (CDH1) is the main driver of invasive lobular breast ...
Spatiotemporal activation of RhoA and actomyosin contraction underpins cellular adhesion and divisio...
Although mutational inactivation of E-cadherin (CDH1) is the main driver of invasive lobular breast ...
Spatiotemporal activation of RhoA and actomyosin contraction underpins cellular adhesion and divisio...
Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term la...
Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term la...
Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term la...